JW Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

JW Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-21,482	Closed	-$1.82M	–	19
2018 Q4	$1.82M	Hold	21,482	–	–	1.34%	12
2018 Q3	$3.68M	Hold	21,482	–	–	1.98%	11
2018 Q2	$2.78M	Hold	21,482	–	–	1.77%	13
2018 Q1	$2.21M	Hold	21,482	–	–	2.18%	12
2017 Q4	$1.83M	Hold	21,482	–	–	1.95%	14
2017 Q3	$1.82M	Hold	21,482	–	–	1.34%	19
2017 Q2	$1.63M	Sell	21,482 -6,412	-23%	-$449K	1.04%	20
2017 Q1	$1.84M	Sell	27,894 -29,952	-52%	-$1.97M	0.38%	22
2016 Q4	$3.67M	Sell	57,846 -11,362	-16%	-$717K	2.44%	11
2016 Q3	$4.41M	Buy	69,208 +11,221	+19%	+$824K	3.03%	9
2016 Q2	$4.31M	Hold	57,987	–	–	3.43%	10
2016 Q1	$3.87M	Hold	57,987	–	–	2.53%	12
2015 Q4	$3.92M	Hold	57,987	–	–	1.46%	16
2015 Q3	$3.1M	Buy	57,987 +539	+0.9%	+$32.7K	1.12%	21
2015 Q2	$3.62M	Buy	57,448 +1,313	+2%	+$71.6K	1.1%	18
2015 Q1	$2.7M	Buy	56,135 +3,674	+7%	+$141K	1.17%	22
2014 Q4	$1.74M	Buy	+52,461	New	+$1.71M	1.31%	17

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

JW Asset Management's LGND Position: Q1 2019 in Review

JW Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q1 2019, closing a stake of 21,482 shares — an estimated $1.82M sold.

JW Asset Management first reported a position in LGND in Q4 2014 and held it in 17 quarters. The position peaked at $4.41M in Q3 2016. 330 funds tracked by Wall St. Rank hold LGND as of Q1 2019.

JW Asset Management reported no remaining Ligand Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
JW Asset Management sold 21,482 Ligand Pharmaceuticals shares in Q1 2019, an estimated $1.82M.
JW Asset Management first reported a position in Ligand Pharmaceuticals in Q4 2014 and held it in 17 quarters.
JW Asset Management's Ligand Pharmaceuticals position peaked at $4.41M in Q3 2016.
330 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2019.

Based on JW Asset Management's 13F filing for Q1 2019, filed 14 May 2019.